Last Updated: August 9, 2026

Suppliers and packagers for POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Baxter Hlthcare POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 019904 NDA Baxter Healthcare Corporation 0338-0703-41 24 BAG in 1 CARTON (0338-0703-41) / 50 mL in 1 BAG 1989-12-26
Baxter Hlthcare POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 019904 NDA Baxter Healthcare Corporation 0338-0703-48 24 BAG in 1 CARTON (0338-0703-48) / 100 mL in 1 BAG 1989-12-26
Baxter Hlthcare POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 019904 NDA Baxter Healthcare Corporation 0338-0705-41 24 BAG in 1 CARTON (0338-0705-41) / 50 mL in 1 BAG 1989-12-26
Baxter Hlthcare POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 019904 NDA Baxter Healthcare Corporation 0338-0705-48 24 BAG in 1 CARTON (0338-0705-48) / 100 mL in 1 BAG 1989-12-26
Baxter Hlthcare POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 019904 NDA Baxter Healthcare Corporation 0338-0709-48 24 BAG in 1 CARTON (0338-0709-48) / 100 mL in 1 BAG 1989-12-26
Otsuka Icu Medcl POTASSIUM CHLORIDE 30MEQ IN PLASTIC CONTAINER potassium chloride INJECTABLE;INJECTION 020161 NDA ICU Medical Inc. 0990-7074-26 24 POUCH in 1 CASE (0990-7074-26) / 1 BAG in 1 POUCH / 100 mL in 1 BAG 2019-04-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers for Potassium Chloride 30 mEq in Plastic Container

Last updated: May 2, 2026

What is the product scope?

Potassium Chloride 30 mEq in plastic container” is typically a liquid, oral formulation supplied in plastic bottles/bags used for electrolyte replacement. In procurement and distribution, it is often listed under variations of:

  • Potassium Chloride Injection (IV/IR formulations)
  • Potassium Chloride Oral Solution (PO formulations)
  • Concentration reference: 30 mEq (commonly tied to bottle/volume labeling rather than a universal mg/mL standard)

Because supplier listings depend on route (oral vs injection), concentration, and container specification, the supplier set differs materially across regions and product presentations.

Who are the supplier categories for this drug?

1) Market makers (brand and label holders)

Supply generally starts with the label holder/manufacturer and flows through distributors:

  • Brand and generic manufacturers (produce the API and/or finished dosage form)
  • Private-label manufacturers (make under distributor brands)
  • Parallel importers (where allowed)

2) Wholesalers and distributors (procurement-facing suppliers)

Most hospitals, pharmacies, and government buyers source through:

  • National pharmaceutical wholesalers
  • Regional pharmaceutical distributors
  • GPO channel partners (in the US)

3) Procurement platforms

Where direct manufacturer delivery is not practical, suppliers route through:

  • Contract purchasing networks
  • Hospital formulary distributors
  • Online pharmaceutical wholesalers (varies by country)

Which suppliers actually sell this presentation?

No complete, authoritative supplier list can be produced from the information provided. “Potassium Chloride 30 mEq in plastic container” is not a unique identifier and does not specify:

  • Route (oral vs injection)
  • NDC/GTIN
  • Strength basis (mEq per mL, per unit volume, or per total container)
  • Container type (bottle, HDPE, IV bag, ampoule pack)
  • Country/market

Without those identifiers, any supplier list would risk mixing different products and container presentations.

What procurement-ready identifiers map to suppliers?

To connect this product to real suppliers, buyers normally use one or more of:

  • NDC (US), EAN/GTIN (EU/global)
  • Dosage form (oral solution vs injection)
  • Strength and total content (mEq per container)
  • Container material and size (e.g., HDPE bottle size, bag volume)
  • Regulatory pathway (brand vs generic)

If the target is strictly “30 mEq per container in plastic,” the NDC/GTIN and route must match exactly, because potassium chloride injection and oral potassium chloride differ in formulation and safety labeling.


Key Takeaways

  • “Potassium Chloride 30 mEq in plastic container” is not a unique product identifier; supplier rosters depend on route, strength basis, and container configuration.
  • A procurement-grade supplier list requires route plus NDC/GTIN (or equivalent market identifier) to avoid cross-listing different potassium chloride products.
  • Build supplier sourcing off the exact presentation used by your formulary or purchasing system (NDC/GTIN first, then distributors/manufacturers).

FAQs

1) Can the same supplier sell both oral and injection potassium chloride 30 mEq?
Often no. Oral solutions and injections are regulated and manufactured under different product specifications and distribution channels.

2) What is the fastest way to identify suppliers for this product?
Use the exact market identifier (NDC/GTIN) tied to the specific route and container presentation, then map to authorized distributors.

3) Are wholesalers the primary suppliers for hospitals?
Yes, most hospital procurement routes through authorized wholesalers and GPO channels rather than direct-from-manufacturer purchasing.

4) Does container material (plastic) change the supplier list?
Yes. Container type and configuration (bottle vs bag, size, material) are part of the finished-product definition that drives manufacturer and distributor eligibility.

5) Why do supplier lists differ by country?
Different regulatory approvals, labeling standards, and distribution networks determine which finished products each manufacturer and wholesaler can legally sell in a given market.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.